The economics of treating chronic hepatitis B in Asia
10.1007/s12072-008-9049-2
Saved in:
Main Authors: | Dan, Y.Y., Lim, S.G., Aung, M.O. |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/26932 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Medical and economic burden of chronic hepatitis B patients at Queen Savang Vadhana Memorial Hospital
by: Chuenrutai Yeekian
Published: (2023) -
How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore
by: Ong, S.C., et al.
Published: (2014) -
A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
by: Narisa Tantai, et al.
Published: (2017) -
Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
by: Ahn, S.H., et al.
Published: (2011) -
EFFECTS OF INTERFERON TREATMENT ON HBV PRE-CORE MUTANTS IN CHRONIC HEPATITIS B CARRIERS IN SINGAPORE
by: LIAU LIAN SOON
Published: (2019)